Influence of [(18)F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients—A PET/CT Registry Study

There is a lack of evidence regarding the clinical impact of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography ([(18)F]FDG-PET/CT, hereinafter referred to as PET/CT), especially regarding management changes and their link to overall survival. We analyzed 52 PET/CTs in 47 sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Sebastian, Sekler, Julia, Gückel, Brigitte, la Fougère, Christian, Nikolaou, Konstantin, Pfannenberg, Christina, Preibsch, Heike, Engler, Tobias, Olthof, Susann-Cathrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378166/
https://www.ncbi.nlm.nih.gov/pubmed/37510164
http://dx.doi.org/10.3390/diagnostics13142420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378166/
https://www.ncbi.nlm.nih.gov/pubmed/37510164
http://dx.doi.org/10.3390/diagnostics13142420

Ejemplares similares